Ceritinib is a tyrosine kinase inhibitor that selectively and potently inhibits anaplastic lymphoma kinase (ALK). In regular physiology, ALK functions as being a essential action in the development and performance of anxious procedure tissue. Nevertheless, chromosomal translocation and fusion give rise to an oncogenic type of ALK that has been https://michaelz221myi4.wikihearsay.com/user